St George's , University of London (SGUL) selects GenoLogics platform and data management system to aid biomarker discovery and systems biology research
GenoLogics Life Sciences Software reports that the St George's, University of London (SGUL) Medical Biomics Centre has selected GenoLogics to provide lab and scientific data management.
The SGUL Medical Biomics Centre is a centre for the integration of genomics, transcriptomics, proteomics and metabolomics technologies applied to medical and biomedical research.
It is well provisioned with cutting edge instrumentation and has a significant track record across systems biology areas with proven success in biomarker discovery, identification and validation.
According to SGUL's Gary Coulton, associate dean for enterprise and innovation: "We needed to address the data deluge coming from our diverse research activities and to provide a secure environment for data management.
"Our major need was a Lims and data management system capable of integrating multiple technologies and also handling data from many research teams (currently over 50), including our academic, clinical and commercial partners.
"It needed to be flexible and user friendly but designed to be able to satisfy both academic and industrial users.
We felt our ideal system had to provide data security but also have provision for web-access by external collaborators.
"It had to be scalable and have the potential for future development.
"We looked at a number of systems all of which had strengths but we felt that Proteuslims from GenoLogics best met our criteria".
The system combines the proven capability of managing the complex data arising from conventional proteomic studies with the flexibility to accommodate new approaches developed within the Medical Biomics Centre.
"The SGUL team was also impressed by GenoLogics' commitment to developing a system that will accommodate the wide variety of data arising from integration of the different biomic technologies.
"We also rapidly developed a strong collaborative relationship with GenoLogics that is very important to us and is the basis for this new partnership", says Coulton.
Michael Ball, CEO of GenoLogics noted: "We very much value our customers' input and partnering with customers has helped us be the leader of purposed systems biology lab and data management solutions for research organisations and companies involved in biomarker and drug discovery.
"Customers are clear they need a solution that will enable data sharing across proteomics, genomics and other science domains and GenoLogics' open integrating platform and data management solution is designed perfectly for that purpose."
